Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Oxford BioMedica
Life Sciences
Deal-making drives first annual profit
02 Apr 2019
Primary Health Properties
Property
Step change, with MedicX Fund merger
By
Mike Foster
28 Mar 2019
Stay up-to-date with the latest research
Sign up to our newsletter
DP Poland Plc
Consumer
FY18 results announced
By
Jason Streets
26 Mar 2019
Property
“Secure income” REITs – Safe Harbour Available
By
Mike Foster
22 Mar 2019
Palace Capital
Property
Hudson Quarter, York, development commences
By
Mike Foster
21 Mar 2019
Volta Finance
Financials
Manager’s March 2019 presentation
By
Mark Thomas
21 Mar 2019
The 600 Group
Industrial
Share price decline unmerited on current fundamentals
By
Paul Singer
18 Mar 2019
Allergy Therapeutics plc
Life Sciences
Take an objective view
18 Mar 2019
Morses Club Plc
Financials
Home collect and online lending acquisitions
By
Mark Thomas
15 Mar 2019
LightwaveRF
Technology
Switch to Smart
By
Milan Radia
13 Mar 2019
Allergy Therapeutics plc
Life Sciences
Strong operating performance driving market share
06 Mar 2019
Prev
1
...
50
51
52
53
54
...
75
Next